UBS Group’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
VCM
VPM
UBS Group's XYL Position: Q1 2026 in Review
UBS Group reduced its Xylem (XYL) stake by 10% in Q1 2026, selling an estimated $16.1M and leaving 1,075,083 shares worth $128M. The position accounts for 0.02% of the portfolio, ranked #862.
UBS Group first reported a position in XYL in Q4 2014 and has held it in 46 quarters since. The position peaked at $235M in Q4 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- UBS Group held 1,075,083 shares of Xylem worth $128M as of Q1 2026.
- UBS Group sold 122,952 Xylem shares in Q1 2026, an estimated $16.1M.
- Xylem made up 0.02% of UBS Group's portfolio in Q1 2026, its #862 holding.
- UBS Group first reported a position in Xylem in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Xylem position peaked at $235M in Q4 2024.
- 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.